Contributor Page
Singh & Associates
 
Email  |  Website  |  Articles
Contact Details
Tel: +91 11 46667000
Fax: +91 11 46667001
E-337, East of Kailash
New Delhi
110065
India
Awards
Contributor Most Read
Contributor Most Read
Contributor Most Read
Contributor Most Read
By Singh & Associates
Hon'ble Supreme Court of India paved way in upholding the momentous judicial precedent which lays down a crucial legal principle pertaining to arbitration proceedings in India w.r.t. power of a civil court in granting the anti-arbitration relief.
By Singh & Associates
On January 15, 2019 EMA's Pharmacovigilance Risk Assessment Committee recommended an EU-wide suspension of fenspiride medicines due to the risk of QT prolongation and torsades de pointes ...
By Singh & Associates
On February 28, 2019, European Medicine Agency published the first guidance on new rules for certain medical devices - the first of a series of guidance documents to help applicants to prepare for compliance with these new rules.
By Singh & Associates
In February 2019, the Government of India introduced first draft regulatory guidelines for evaluation of nanopharmaceutical products for therapeutic use in the country.
By Singh & Associates
On February 26, 2019 Central Government published draft amendment to the Drug & Cosmetic Rules, 19459 to include a clause where a manufacturer / applicant intending to market a drug under a brand name ...
By Singh & Associates
Central Government, in order to enhance the safety of the cosmetic products, has proposed the product composition details clause shall be mentioned in the approval issued by the licensing authority in the country.
By Singh & Associates
On February 27, 2019, the National Pharmaceutical Pricing Authority or NPPA capped trade margins of 42 non-scheduled cancer drugs to curb profiteering on vital medicines notified in the Standing Order.
By Singh & Associates
AMR is a major global challenge and is getting the attention of all relevant stakeholders. Factors such as inappropriate and irrational use of antimicrobial agents among others have led to the increase in AMR.
By Singh & Associates
On February 15, 2019, the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers issued six draft QCOs, after consulting with the Bureau of Indian Standards to ensure safety and effectiveness of these medical devices:
By Singh & Associates
On February 08, 2019, the Central Government announced that all Implantable Medical Devices along with CT scan Equipment, MRI Equipment, Defibrillators, Dialysis Machine, PET Equipment, X-Ray Machine, and ...
By Kartikeya Prasad
Barbadian singer, songwriter, and actress Robyn Rihanna Fenty recently decided to sue her father Ronald Fenty to stop him from using the "Fenty" trademark.
By Heena Lamba
WIPO DAS stands for World Intellectual Property Organization-Digital Access Service.
By Khushboo Tomar
It is a thin line of difference between the two but is extremely significant.
By Samridh Ahuja
Levola, in this case, had relied on a Dutch Supreme Court ruling in Lancôme v Kefoca3 where it was held that the smell of a perfume is eligible for copyright protection.
By Singh & Associates
The approval and launch of new medicines/biological products for marketing often means the availability of new treatment for patients and advancement in health care.
Contributor's Topics
More...